[ad_1]
March 27, 2022
1 min watch
Source/Disclosures
Published by:
Source:
Lloyd S. Miller, MD, PhD
Disclosures:
Miller reports being an employee of Janssen Research & Development and owning Johnson & Johnson stocks.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
BOSTON — In this video, Lloyd S. Miller, MD, PhD, of Janssen Research & Development, summarizes Tremfya (guselkumab) data in psoriasis and psoriatic arthritis treatment presented at the American Academy of Dermatology Annual Meeting.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
American Academy of Dermatology Meeting
[ad_2]
Source link